Excipients play a critical role in controlled-release drug formulations. Learn how new direct-compression grades of hypromellose may be used to enhance powder flowability while maintaining tablet quality and controlled-release performance.Brian Koblinski, market development manager in Dow's global pharmaceutical excipients business, explains how formulation scientists and manufacturers can applythese excipients in their formulations.

Mark Hall is Lead Development Specialist within the Pharmaceutical Excipients R&D group of Dow Wolff Cellulosics (DWC). Mark's extensive background in polymer processing established Dow as a leader in Hot Melt Extrusion (HME) technology in the Pharmaceutical industry.  He has 25 external papers/publications and seven issued patents.  He joined Dow after receiving BS and MS degrees in Chemistry from Clarkson University.